TFG Asset Management’s Acadia Pharmaceuticals ACAD Stock Holding History

TFG Asset Management’s Portfolio ACAD Stock Details ACAD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$4.25M	Buy	167,875 +23,255	+16%	+$512K	0.67%	28
2026 Q1	$3.22M	Buy	+144,620	New	+$3.46M	0.63%	27
2025 Q4	–	Sell	-86,071	Closed	-$1.84M	–	30
2025 Q3	$1.84M	Sell	86,071 -75,325	-47%	-$1.78M	0.25%	31
2025 Q2	$3.48M	Buy	161,396 +54,396	+51%	+$1.01M	0.56%	22
2025 Q1	$1.78M	Buy	+107,000	New	+$1.94M	0.41%	22

Other funds holding ACAD

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

TFG Asset Management's ACAD Position: Q2 2026 in Review

TFG Asset Management increased its Acadia Pharmaceuticals (ACAD) stake by 16% in Q2 2026, buying an estimated $512K and bringing the position to 167,875 shares worth $4.25M. The position accounts for 0.67% of the portfolio, ranked #28.

TFG Asset Management first reported a position in ACAD in Q1 2025 and has held it in 5 quarters since. 352 funds tracked by Wall St. Rank hold ACAD as of Q2 2026.

TFG Asset Management held 167,875 shares of Acadia Pharmaceuticals worth $4.25M as of Q2 2026.
TFG Asset Management bought 23,255 Acadia Pharmaceuticals shares in Q2 2026, an estimated $512K.
Acadia Pharmaceuticals made up 0.67% of TFG Asset Management's portfolio in Q2 2026, its #28 holding.
TFG Asset Management first reported a position in Acadia Pharmaceuticals in Q1 2025 and has held it in 5 quarters since.
352 funds tracked by Wall St. Rank held Acadia Pharmaceuticals as of Q2 2026.

Based on TFG Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.